PURPOSE: The aims of this study were to investigate the impact of individual health-related quality of life (HRQL) evaluation on the attention towards symptom control and psychosocial function in advanced cancer patients. METHODS:Patients with advanced lung cancer or mesothelioma who attended a pulmonary oncology outpatient clinic were randomized to either of two strategies for HRQL assessment. The experimental group (EG) answered the EORTC QLQ-C30 + LC13 questionnaire using a digital table interface, with outprint of aggregated scale scores presented to the consulting physician as a support for evaluation. The control group (CG) answered a paper version of the same questionnaire, which was stored for later analysis. Consultations were audio-recorded. Outcome measures were a quantitative content analysis of audio-recorded consultations and medical and psychosocial interventions abstracted from clinical records. RESULTS:One hundred seventy-one patients were randomized and participated in the study. Issues regarding emotional function were more frequently discussed during consultations in the EG (p < 0.05). Similarly, interventions directed to emotional and social concerns were more frequent in the EG (p = 0.013 and p = 0.0036, respectively). HRQL measures over time were similar across the groups. CONCLUSION: Individual HRQL assessment increased the attention to psychosocial functioning in patients with chest malignancies.
RCT Entities:
PURPOSE: The aims of this study were to investigate the impact of individual health-related quality of life (HRQL) evaluation on the attention towards symptom control and psychosocial function in advanced cancerpatients. METHODS:Patients with advanced lung cancer or mesothelioma who attended a pulmonary oncology outpatient clinic were randomized to either of two strategies for HRQL assessment. The experimental group (EG) answered the EORTC QLQ-C30 + LC13 questionnaire using a digital table interface, with outprint of aggregated scale scores presented to the consulting physician as a support for evaluation. The control group (CG) answered a paper version of the same questionnaire, which was stored for later analysis. Consultations were audio-recorded. Outcome measures were a quantitative content analysis of audio-recorded consultations and medical and psychosocial interventions abstracted from clinical records. RESULTS: One hundred seventy-one patients were randomized and participated in the study. Issues regarding emotional function were more frequently discussed during consultations in the EG (p < 0.05). Similarly, interventions directed to emotional and social concerns were more frequent in the EG (p = 0.013 and p = 0.0036, respectively). HRQL measures over time were similar across the groups. CONCLUSION: Individual HRQL assessment increased the attention to psychosocial functioning in patients with chest malignancies.
Authors: J de Haes; D Curran; T Young; A Bottomley; H Flechtner; N Aaronson; J Blazeby; K Bjordal; Y Brandberg; E Greimel; J Maher; M Sprangers; A Cull Journal: Eur J Cancer Date: 2000-05 Impact factor: 9.162
Authors: Morten Aa Petersen; Mogens Groenvold; Neil K Aaronson; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Peter Fayers; Jorunn Helbostad; Bernhard Holzner; Stein Kaasa; Susanne Singer; Galina Velikova; Teresa Young Journal: Qual Life Res Date: 2010-10-23 Impact factor: 4.147
Authors: Carol Tishelman; Malin Lövgren; Eva Broberger; Katarina Hamberg; Mirjam A G Sprangers Journal: J Clin Oncol Date: 2010-03-08 Impact factor: 44.544
Authors: Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Mehul K Soni; David Cella; Gregory A Masters; Steven P Burch; Anne Heyes; Cheryl Silberman Journal: Clin Lung Cancer Date: 2002-11 Impact factor: 4.785
Authors: Sarah K Rosenbloom; David E Victorson; Elizabeth A Hahn; Amy H Peterman; David Cella Journal: Psychooncology Date: 2007-12 Impact factor: 3.894
Authors: Heather S L Jim; Aasha I Hoogland; Naomi C Brownstein; Anna Barata; Adam P Dicker; Hans Knoop; Brian D Gonzalez; Randa Perkins; Dana Rollison; Scott M Gilbert; Ronica Nanda; Anders Berglund; Ross Mitchell; Peter A S Johnstone Journal: CA Cancer J Clin Date: 2020-04-20 Impact factor: 508.702
Authors: Vincenzo O Palmieri; Daniela Santovito; Francesco Margari; Madia Lozupone; Francesco Minerva; Carla Di Gennaro; Orlando Todarello; Giuseppe Palasciano Journal: Clin Exp Med Date: 2013-12-10 Impact factor: 3.984
Authors: Tom Lormans; Everlien de Graaf; Joep van de Geer; Frederieke van der Baan; Carlo Leget; Saskia Teunissen Journal: Palliat Med Date: 2021-04-20 Impact factor: 4.762
Authors: Sarah King; Josephine Exley; Sarah Parks; Sarah Ball; Teresa Bienkowska-Gibbs; Calum MacLure; Emma Harte; Katherine Stewart; Jody Larkin; Andrew Bottomley; Sonja Marjanovic Journal: Qual Life Res Date: 2016-04-02 Impact factor: 4.147
Authors: Caitlin Graupner; Merel L Kimman; Suzanne Mul; Annerika H M Slok; Danny Claessens; Jos Kleijnen; Carmen D Dirksen; Stéphanie O Breukink Journal: Support Care Cancer Date: 2020-09-02 Impact factor: 3.603